FDA FDA Seeks Comments on Transparency and Communication for New Entities Thomas Sullivan Jul 23, 2012 0 The Food and Drug Administration (FDA) recently announced an opportunity for public comment on the statement of work for an…
Uncategorized The Food and Drug Administration Safety and Innovation Act (FDASIA):… Thomas Sullivan Jul 19, 2012 0 The Food and Drug Administration Safety and Innovation Act (FDASIA), signed into law on July 9, 2012, gives FDA the authority to…
Drug Shortages FDA: Recently Signed PDUFA 5 Provisions to Address Drug Shortages Thomas Sullivan Jul 18, 2012 1 On July 9, 2012, President Obama signed into law the Food and Drug Administration Safety and Innovation Act (FDASIA), which gives…
FDA FDA: Food and Drug Administration Safety and Innovation Act (FDASIA) and… Thomas Sullivan Jul 17, 2012 0 Last week, President Obama signed into law the Food and Drug Administration Safety and Innovation Act (FDASIA). Among the numerous…
CME FDA Releases Final Risk Evaluation and Mitigation Strategies (REMS) for… Thomas Sullivan Jul 9, 2012 0 After three years of work the Food and Drug Administration (FDA) released its final Risk Evaluation and Mitigation Strategies…
CME FDA REMS: Blue Print for Prescriber Continuing Education Program for… Thomas Sullivan Nov 8, 2011 0 The Food and Drug Administration (FDA) released a “Blueprint for Prescriber Continuing Education Program” regarding the use of…
Congress The Cultivating Scientific Expertise to Foster Innovation for Patients Act… Thomas Sullivan Oct 20, 2011 0 As we noted last week, a group of bipartisan Senators including Senators Amy Klobuchar (D-MN), Richard Burr (R-NC), and Michael…
Medical Legal Par Pharmaceuticals vs. FDA Calling for Truthful Speech vs. FDA Approved Thomas Sullivan Oct 18, 2011 0 Last June, the United States Supreme Court, in a landmark decision, invalidated a Vermont law, which tried to restrict commercial…
FDA FDA Updates 510K Approval Process for Medical Devices Thomas Sullivan Jan 20, 2011 0 This week, the Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) announced new actions for the…
Uncategorized Health Advocacy Organizations and the Pharmaceutical Industry: An Analysis… Thomas Sullivan Jan 19, 2011 0 Patients dying of cancer or suffering from diabetes often do not have the means to advocate for more research or treatments to…